Retrospective analysis of the usefulness of a protocol with high-dose methotrexate in polymyalgia rheumatica: Results of a single-center cohort of 100 patients.
Luca QuartuccioGiorgia GregoraciMiriam IsolaSalvatore De VitaPublished in: Geriatrics & gerontology international (2018)
MTX up to 20 mg/day was useful in defined subsets of polymyalgia rheumatica, also in the long term. No significant differences were noticed among the five subgroups. Geriatr Gerontol Int 2018; 18: 1410-1414.